Alginate Meniscus Repair Composition for Avascular Fibrocartilage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for meniscus injuries, particularly in avascular areas, lack effective methods to regenerate fibrocartilage and restore mechanical strength without using cells or tissues, and often result in incomplete healing or further damage due to the lack of self-repairing capacity.
Innovation Solution
A composition comprising a low endotoxin monovalent metal salt of alginic acid, such as sodium alginate, is applied to the injured meniscus, providing fluidity and adhesion to fill and regenerate the injured area, promoting regeneration of fibrocartilage and restoring mechanical strength.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous chondrocyte implantation or allografts are used to treat fibrocartilage tissue damage, then the damaged tissue can be replaced, but the treatment is invasive, requires multiple surgical procedures, and has limited availability
Solution Approach 1:
Chondrocytes are harvested and expanded in culture before the implantation procedure. This preliminary expansion allows a sufficient number of cells to be obtained from a small initial biopsy, enabling effective tissue replacement while reducing the invasiveness and complexity of the overall treatment procedure.
Solution Approach 2:
A collagen matrix serves as an intermediary carrier that delivers the expanded chondrocytes to the defect site. This matrix provides structural support and facilitates cell integration, eliminating the need for multiple surgical procedures while maintaining reliable tissue replacement.
2Device complexity
If microfracture technique is used to stimulate endogenous repair, then the procedure is simpler and less invasive, but fibrocartilage forms instead of hyaline cartilage, resulting in inferior repair quality
Solution Approach 1:
The treatment applies different qualities to different aspects of the repair process: the microfracture technique creates local channels for cell infiltration, while the added expanded chondrocytes provide the specific hyaline cartilage-forming cells needed. This combination maintains procedural simplicity while ensuring high-quality hyaline cartilage formation rather than inferior fibrocartilage.
Solution Approach 2:
The technique changes the cellular parameter by introducing exogenous hyaline cartilage-forming chondrocytes to the defect site. This parameter change ensures that the repair tissue is hyaline cartilage with superior mechanical and biochemical properties, rather than fibrocartilage, while keeping the microfracture procedure itself simple and minimally invasive.
3Device complexity
If acellular matrices are used for cartilage repair, then the implantation is simplified, but the matrices lack living cells and growth factors necessary for effective tissue regeneration
Solution Approach 1:
The treatment merges two approaches: the simplicity of acellular matrix implantation with the biological activity of living chondrocytes. Expanded chondrocytes are seeded onto the collagen matrix before implantation, combining the ease of matrix handling with the regenerative capacity of living cells and their associated growth factors.
Solution Approach 2:
The treatment uses a composite structure where living chondrocytes are incorporated into the collagen matrix. This composite provides both the structural framework of the matrix and the biological activity of the cells, achieving simplified implantation while ensuring sufficient biologically active components for effective tissue regeneration.
Data Source
Figure 1A~1C
Figure 2A~2B
Figure 3A~3B
AI summary
The present invention has an objective of providing a novel composition for treating a fibrocartilaginous tissue injury. The present invention provides a composition for treating a fibrocartilaginous tissue injury, which is to be applied to an injured fibrocartilaginous tissue part of a target and which comprises a monovalent metal salt of alginic acid, more preferably a low endotoxin monovalent metal salt of alginic acid.